


Robocath receives NMPA approval for R-One robotic platform in China
© Robocath

Omini receives EU patent approval for electrochemical based sensor used for multiplexed blood testing platform
© Jérémy Barande – Ecole Polytechnique

Orphelia Pharma secures US patent covering KIZFIZO®, first drinkable formulation of temozolomide
Jeremy Bastid

Provepharm obtains B Corp™ certification
© Yann Bouvier

Cell-Easy and Toulouse University Hospital obtain IMPD approval for first-in-human clinical trial in systemic sclerosis, using promising allogeneic approach
© Cell-Easy

Orphelia Pharma files EU marketing authorization application for KIZFIZO®

CardioRenal receives FDA Breakthrough Device Designation for TENOR
© CardioRenal

Carthera announces positive outcome of End-of-Phase 2 meeting with FDA for SonoCloud-9 system for treatment of recurrent glioblastoma
